Stock MYLAN INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Mylan Inc Nasdaq

Equities

US6285301072

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Mylan Inc
06-27 European Commission Conditionally Approves Cooper-Viatris Deal MT
06-11 Transcript : Viatris Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 09:20 AM

Chart calendar Mylan Inc

75c029e26d0375143cd154baab4b5c.nW5Fnw6yattPeJ4zaWxpBX9WIeBlhcewV25W2ZR6GHw.7CM2zlHTJ6MKF7NFHi82cBoOS6USxvGEIRQXu-UWeSTyKAb0b8QyrR0q6Q~f485876709776b68640e2d8b9316aa39

Upcoming events on Mylan Inc

2024-08-07 Q2 2024 Earnings Release Pre-market
2024-08-08 08:30 Q2 2024 Earnings Call
2024-11-03 Q3 2024 Earnings Release (Projected)
2025-03-02 Q4 2024 Earnings Release (Projected)
2025-05-11 Q1 2025 Earnings Release (Projected)
2025-08-10 Q2 2025 Earnings Release (Projected)

Past events on Mylan Inc

2024-06-11 09:20 Goldman Sachs Global Healthcare Conference
2024-06-06 08:00 Jefferies Global Healthcare Conference
2024-05-22 Détachement de
2024-05-14 13:00 BofA Securities Health Care Conference
2024-05-09 08:30 Q1 2024 Earnings Call
2024-05-09 06:59 Q1 2024 Earnings Release
2024-03-27 10:00 R&D Day
2024-03-07 Détachement de
2024-02-28 08:30 Q4 2023 Earnings Call
2024-02-28 06:30 Q4 2023 Earnings Release
2024-01-10 13:30 JPMorgan Healthcare Conference
2023-12-15 11:00 Annual General Meeting
2023-11-21 Détachement de
2023-11-15 04:30 Jefferies London Healthcare Conference
2023-11-07 17:00 Q3 2023 Earnings Call
2023-11-07 16:02 Q3 2023 Earnings Release
2023-08-22 Détachement de
2023-08-07 08:30 Q2 2023 Earnings Call
2023-08-07 06:59 Q2 2023 Earnings Release
2023-06-13 16:20 Goldman Sachs Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		11 501
11 537
-0.32%		11 946
12 273
-2.66%		17 886
17 881
0.03%		16 263
16 372
-0.67%		15 427
15 465
-0.25%
14 981

EBITDA
Million USD		Released
Forecast
Spread 		3 540
3 500
1.12%		3 654
4 483
-18.49%		6 426
6 464
-0.59%		5 777
5 852
-1.29%		5 124
5 197
-1.4%
4 819

EBIT
Million USD		Released
Forecast
Spread 		3 264
3 212
1.62%		3 376
3 864
-12.61%		6 046
6 111
-1.07%		5 475
5 566
-1.62%		4 725
4 851
-2.6%
4 493

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		154
807
-80.87%		-721
3 677
-119.61%		-664
-580
-14.55%		2 813
878
220.41%		203
1 198
-83.06%
3 933

Net income
Million USD		Released
Forecast
Spread 		16,8
427
-96.07%		-670
1 449
-146.24%		-1 269
-952
-33.29%		2 079
1 328
56.46%		54,7
812
-93.26%
1 812

EPS
USD		Released
Forecast
Spread 		0,03
0,81
-96.3%		-1,11
1,62
-168.59%		-1,05
-0,77
-36.36%		1,71
1,01
69.62%		0,05
0,84
-94.02%
1,33

Announcement Date27/02/2001/03/2128/02/2227/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		4 192
4 258
-1.55%		4 117
4 185
-1.62%		4 078
4 136
-1.39%		3 876
3 988
-2.8%		3 729
3 812
-2.18%		3 919
3 862
1.45%		3 942
3 997
-1.37%		3 837
3 877
-1.03%		3 663
3 691
-0.75%
3 718


3 809


3 789


3 739


3 849

EBITDA
Million USD		Released
Forecast
Spread 		1 586
1 445
9.8%		1 482
1 443
2.73%		1 498
1 431
4.69%		1 211
1 288
-6%		1 341
1 222
9.69%		1 306
1 255
4.04%		1 360
1 293
5.2%		1 117
1 220
-8.44%		1 193
1 207
-1.13%
1 183


1 249


1 237







EBIT
Million USD		Released
Forecast
Spread 		1 551
1 375
12.82%		1 425
1 375
3.57%		1 415
1 368
3.4%		1 085
1 166
-6.96%		1 255
1 151
9.02%		1 226
1 178
4.12%		1 257
1 208
4.05%		987
1 100
-10.29%		1 100
1 104
-0.38%
1 117


1 166


1 117


1 111


1 101

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		528
48,0
998.96%














402
260
54.69%		-855
140
-710.71%



3 164


310


255







Net income
Million USD		Released
Forecast
Spread 		399
149
167.56%		314
234
34.21%		354
357
-0.78%		1 011
257
292.86%		225
154
46.31%		264
225
17.13%		332
246
35.03%		-766
114
-771.58%		114
123
-7.07%
1 269


200


229







EPS
USD		Released
Forecast
Spread 		0,33
0,08
304.11%		0,26
0,19
36.43%		0,29
0,42
-31.07%		0,83
0,15
453%		0,19
0,23
-15.82%		0,22
0,20
8.2%		0,27
0,34
-20.08%		-0,64
0,26
-344.8%		0,09
0,12
-22.89%
0,14


0,21


0,32







Announcement Date09/05/2208/08/2207/11/2227/02/2308/05/2307/08/2307/11/2328/02/2409/05/24-----

Upcoming sector events for Mylan Inc

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 06:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Mylan Inc

2024-06-21 11:28 DEVA HOLDING: Q1 2024 Earnings Release
2024-06-13 17:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
2024-06-11 01:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
2024-06-07 06:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
2024-06-07 05:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
2024-05-30 08:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. VTRS Stock
  4. Stock
  5. Calendar Mylan Inc